Biopharmaceutical company focused on microRNA (miRNA)-directed oncology therapies
- Year invested 2012
- Investment Stage Early
- Sectors
- Investment Status Historic
- Associated Team
- Website mirnatherapeutics.com/
- Company Status IPO/Public (Nasdaq: MIRN)
Biopharmaceutical company focused on microRNA (miRNA)-directed oncology therapies